Candidemia in a Pediatric Center and Importance of Central Venous Catheter Removal
|ClinicalTrials.gov Identifier: NCT02088476|
Recruitment Status : Completed
First Posted : March 17, 2014
Last Update Posted : March 17, 2014
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||248 participants|
|Study Start Date :||January 2004|
|Actual Primary Completion Date :||December 2012|
|Actual Study Completion Date :||June 2013|
Candidemia is defined as the presence of growth of any candida species in at least one blood culture obtained by either peripheral venipuncture or through an indwelling central venous catheter.
- Risk factors of candidemia [ Time Frame: up to 3 months ]The presence or absence of potential risk factors for candidemia such as an indwelling central venous catheter (CVC), use of antibiotics (administered for >72 hours), use of antifungals (administered for >24 hours), immunosuppressants, total parenteral nutrition (TPN), admission to the intensive care unit (ICU), mechanical ventilation, neutropenia, hypoalbuminemia and hypophosphatemia.
- Prognosis according to candida species [ Time Frame: up to 3 months ]Death which ensues within 30 days of the onset of candidemia with no apparent alternative cause is recognized as a candidemia-attributable mortality. Patients who died and survived were compared according to candida species (C.albicans, C. parapsilosis, C. tropicalis, C. sake, C.glabrata).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02088476
|Hacettepe University Faculty of Medicine|
|Ankara, Turkey, 06100|